Drug: gemcitabine Quarter: 2016Q3
Total Records: 1,060 Number of Pages: 53
| DRUGNAME | PT | EventCount |
|---|---|---|
| GEMCITABINE | Tumour lysis syndrome | 1 |
| GEMCITABINE | Tumour necrosis | 1 |
| GEMCITABINE | Tumour rupture | 1 |
| GEMCITABINE | Upper respiratory tract infection | 1 |
| GEMCITABINE | Urinary retention | 1 |
| GEMCITABINE | Urinary tract disorder | 1 |
| GEMCITABINE | Urinary tract pain | 1 |
| GEMCITABINE | Urine protein/creatinine ratio increased | 1 |
| GEMCITABINE | Urticaria | 1 |
| GEMCITABINE | Uterine haemorrhage | 1 |
| GEMCITABINE | Vaginal haemorrhage | 1 |
| GEMCITABINE | Vaginal perforation | 1 |
| GEMCITABINE | Vanishing bile duct syndrome | 1 |
| GEMCITABINE | Vascular access complication | 1 |
| GEMCITABINE | Ventricular hypokinesia | 1 |
| GEMCITABINE | Vertebral column mass | 1 |
| GEMCITABINE | Vertigo | 1 |
| GEMCITABINE | Vision blurred | 1 |
| GEMCITABINE | White blood cell count abnormal | 1 |
| GEMCITABINE | White blood cell count increased | 1 |
Total Records: 1,060 Number of Pages: 53